id: phenobarbital_protocol_to_all_cause_30day_readmission
name: Phenobarbital-Based Treatment Protocol â†’ All-Cause 30-Day Hospital Readmission
from_node:
  node_id: phenobarbital_protocol
  node_name: Phenobarbital-Based Treatment Protocol
to_node:
  node_id: all_cause_30day_readmission
  node_name: All-Cause 30-Day Hospital Readmission
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Phenobarbital-based protocol provides more effective stabilization of alcohol
  withdrawal symptoms during hospitalization'
- 'Step 2: Longer half-life of phenobarbital may provide extended protection against
  withdrawal symptoms after discharge'
- 'Step 3: More complete resolution of withdrawal syndrome reduces acute complications
  requiring readmission'
- 'Step 4: Improved clinical stability at discharge reduces risk of medical decompensation
  in the 30-day post-discharge period'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Fadi Hawa et al. 2021. "Phenobarbital Versus Lorazepam for Management
    of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study." *Cureus*. https://doi.org/10.7759/cureus.13282'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.704040'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
